Cipla informs about press release

02 Apr 2020 Evaluate

Cipla has informed that the company has enclosed a press release dated 2nd April 2020 regarding ‘Cipla announces successful completion of Phase-3 clinical study for generic version of GSK’s Advair Diskus’.

The above information is a part of company’s filings submitted to BSE.

Cipla Share Price

1334.85 -12.80 (-0.95%)
02-Mar-2026 12:21 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1744.45
Dr. Reddys Lab 1278.15
Cipla 1334.85
Zydus Lifesciences 901.20
Lupin 2277.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×